标题
CD133: An emerging prognostic factor and therapeutic target in colorectal cancer
作者
关键词
-
出版物
CELL BIOLOGY INTERNATIONAL
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2019-10-03
DOI
10.1002/cbin.11243
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Co-expression and prognostic significance of putative CSC markers CD44, CD133, wild-type EGFR and EGFRvIII in metastatic colorectal cancer
- (2019) Said Abdullah Khelwatty et al. Oncotarget
- Expression of the stem cell marker CD133 is related to tumor development in colorectal carcinogenesis
- (2018) Shinsuke Kazama et al. Asian Journal of Surgery
- MicroRNAs as novel biomarkers for colorectal cancer: New outlooks
- (2018) Naghmeh Shirafkan et al. BIOMEDICINE & PHARMACOTHERAPY
- CD133 expression correlates with clinicopathologic features and poor prognosis of colorectal cancer patients
- (2018) Rongyong Huang et al. MEDICINE
- MicroRNAs in cancer drug resistance: Basic evidence and clinical applications
- (2018) Mehri Ghasabi et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Chitosan nanoparticles as a dual drug/siRNA delivery system for treatment of colorectal cancer
- (2017) Sanam Sadreddini et al. IMMUNOLOGY LETTERS
- Cancer stem cells revisited
- (2017) Eduard Batlle et al. NATURE MEDICINE
- CD133-targeted oncolytic adenovirus demonstrates anti-tumor effect in colorectal cancer
- (2017) Mizuho Sato-Dahlman et al. Oncotarget
- Targeting Colorectal Cancer Stem-Like Cells with Anti-CD133 Antibody-Conjugated SN-38 Nanoparticles
- (2016) Sin-Tzu Ning et al. ACS Applied Materials & Interfaces
- LGR5 and CD133 as prognostic and predictive markers for fluoropyrimidine-based adjuvant chemotherapy in colorectal cancer
- (2016) Luka Stanisavljević et al. ACTA ONCOLOGICA
- CD133 Expression at the Metastatic Site Predicts Patients’ Outcome in Colorectal Cancer with Synchronous Liver Metastasis
- (2016) Junko Kishikawa et al. ANNALS OF SURGICAL ONCOLOGY
- Colorectal Cancer: Epidemiology, Disease Mechanisms and Interventions to Reduce Onset and Mortality
- (2016) Veronica Aran et al. Clinical Colorectal Cancer
- CD133 expression may be useful as a prognostic indicator in colorectal cancer, a tool for optimizing therapy and supportive evidence for the cancer stem cell hypothesis: a meta-analysis
- (2016) Yang Zhao et al. Oncotarget
- Light-controlled endosomal escape of the novel CD133-targeting immunotoxin AC133–saporin by photochemical internalization — A minimally invasive cancer stem cell-targeting strategy
- (2015) Monica Bostad et al. JOURNAL OF CONTROLLED RELEASE
- Targeting CD133high Colorectal Cancer Cells In Vitro and In Vivo With an Asymmetric Bispecific Antibody
- (2015) Lei Zhao et al. JOURNAL OF IMMUNOTHERAPY
- Colorectal cancer stem cell and chemoresistant colorectal cancer cell phenotypes and increased sensitivity to Notch pathway inhibitor
- (2015) RUI HUANG et al. Molecular Medicine Reports
- Patients with CD133-Negative Colorectal Liver Metastasis Have a Poor Prognosis After Hepatectomy
- (2014) Shinya Yamamoto et al. ANNALS OF SURGICAL ONCOLOGY
- Evaluation of Cancer Stem Cell Markers CD133, CD44, CD24: Association with AKT Isoforms and Radiation Resistance in Colon Cancer Cells
- (2014) Sara Häggblad Sahlberg et al. PLoS One
- CD133-targeted paclitaxel delivery inhibits local tumor recurrence in a mouse model of breast cancer
- (2013) Suresh Kumar Swaminathan et al. JOURNAL OF CONTROLLED RELEASE
- MiR-142-3p functions as a tumor suppressor by targeting CD133, ABCG2, and Lgr5 in colon cancer cells
- (2013) Wei-Wei Shen et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- CD133 Expression and the Prognosis of Colorectal Cancer: A Systematic Review and Meta-Analysis
- (2013) Shicai Chen et al. PLoS One
- CD133: A cancer stem cells marker, is used in colorectal cancers
- (2013) Fei Ren WORLD JOURNAL OF GASTROENTEROLOGY
- Cytoplasmic CD133 Expression is a Reliable Prognostic Indicator of Tumor Regression After Neoadjuvant Concurrent Chemoradiotherapy in Patients with Rectal Cancer
- (2012) Shu-Wen Jao et al. ANNALS OF SURGICAL ONCOLOGY
- Prognostic role of CD133 expression in colorectal cancer: a meta-analysis
- (2012) Ke Wang et al. BMC CANCER
- Aberrant expression of CD133 in non-small cell lung cancer and its relationship to vasculogenic mimicry
- (2012) Shiwu Wu et al. BMC CANCER
- Dickkopf-1 inhibits epithelial-mesenchymal transition of colon cancer cells and contributes to colon cancer suppression
- (2012) Lisha Qi et al. CANCER SCIENCE
- Mutations in the Ras-Raf Axis Underlie the Prognostic Value of CD133 in Colorectal Cancer
- (2012) K. Kemper et al. CLINICAL CANCER RESEARCH
- miR-125b regulates the proliferation of glioblastoma stem cells by targeting E2F2
- (2012) Ning Wu et al. FEBS LETTERS
- CD133 as a biomarker for putative cancer stem cells in solid tumours: limitations, problems and challenges
- (2012) Philipp Grosse-Gehling et al. JOURNAL OF PATHOLOGY
- miRNA expression profile of colon cancer stem cells compared to non-stem cells using the SW1116 cell line
- (2012) YANTIAN FANG et al. ONCOLOGY REPORTS
- Protein cross-talk in CD133+ colon cancer cells indicates activation of the Wnt pathway and upregulation of SRp20 that is potentially involved in tumorigenicity
- (2012) Claudia Corbo et al. PROTEOMICS
- Increased expression of CD133 is a strong predictor of poor outcome in stage I colorectal cancer patients
- (2012) Luca Reggiani Bonetti et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- 5-Fluorouracil upregulates the activity of Wnt signaling pathway in CD133-positive colon cancer stem-like cells
- (2012) Yan-Hong Deng et al. Chinese Journal of Cancer
- Tenascin C Induces Epithelial-Mesenchymal Transition–Like Change Accompanied by SRC Activation and Focal Adhesion Kinase Phosphorylation in Human Breast Cancer Cells
- (2011) Keiki Nagaharu et al. AMERICAN JOURNAL OF PATHOLOGY
- Targeting colon cancer stem cells using a new curcumin analogue, GO-Y030
- (2011) L Lin et al. BRITISH JOURNAL OF CANCER
- Clinicopathological significance and prognostic value of CD133 expression in triple-negative breast carcinoma
- (2011) Po Zhao et al. CANCER SCIENCE
- Phenotypic plasticity and epithelial-mesenchymal transitions in cancer and normal stem cells?
- (2011) Christina Scheel et al. INTERNATIONAL JOURNAL OF CANCER
- Targeted Inhibition of CD133+ Cells in Oral Cancer Cell Lines
- (2011) M. Damek-Poprawa et al. JOURNAL OF DENTAL RESEARCH
- A multigene predictor of outcome in glioblastoma
- (2011) H. Colman et al. NEURO-ONCOLOGY
- CD133/Src Axis Mediates Tumor Initiating Property and Epithelial-Mesenchymal Transition of Head and Neck Cancer
- (2011) Yu-Syuan Chen et al. PLoS One
- Establishment of a highly migratory subclone reveals that CD133 contributes to migration and invasion through epithelial–mesenchymal transition in pancreatic cancer
- (2011) Qiang Ding et al. Human Cell
- Cancer Stem Cells and Epithelial-to-Mesenchymal Transition (EMT)-Phenotypic Cells: Are They Cousins or Twins?
- (2011) Dejuan Kong et al. Cancers
- Quantitative Analyses of CD133 Expression Facilitate Researches on Tumor Stem Cells
- (2010) Yongqiang Liao et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Activation of Akt and MAPK pathways enhances the tumorigenicity of CD133+ primary colon cancer cells
- (2010) Y. K. Wang et al. CARCINOGENESIS
- Characteristics of CD133+ Human Colon Cancer SW620 Cells
- (2010) Hironobu Kawamoto et al. CELL TRANSPLANTATION
- Celecoxib enhances radiosensitivity in medulloblastoma-derived CD133-positive cells
- (2010) Kuan-Hsuan Chen et al. CHILDS NERVOUS SYSTEM
- Targeting Wnt Signaling in Colon Cancer Stem Cells
- (2010) E. M. F. de Sousa et al. CLINICAL CANCER RESEARCH
- Clinical Significance of CD133 and Hypoxia Inducible Factor-1α Gene Expression in Rectal Cancer after Preoperative Chemoradiotherapy
- (2010) S. Saigusa et al. CLINICAL ONCOLOGY
- Expression profiling of GIST: CD133 is associated with KIT exon 11 mutations, gastric location and poor prognosis
- (2010) Gabriella Arne et al. INTERNATIONAL JOURNAL OF CANCER
- CD133 expression predicts for non-response to chemotherapy in colorectal cancer
- (2010) Chee W Ong et al. MODERN PATHOLOGY
- Analysis of an alternative human CD133 promoter reveals the implication of Ras/ERK pathway in tumor stem-like hallmarks
- (2010) Kouichi Tabu et al. Molecular Cancer
- Photothermolysis of glioblastoma stem-like cells targeted by carbon nanotubes conjugated with CD133 monoclonal antibody
- (2010) Chung-Hao Wang et al. Nanomedicine-Nanotechnology Biology and Medicine
- Correlation of CD133, OCT4, and SOX2 in Rectal Cancer and Their Association with Distant Recurrence After Chemoradiotherapy
- (2009) Susumu Saigusa et al. ANNALS OF SURGICAL ONCOLOGY
- Expression of gastrin precursors by CD133-positive colorectal cancer cells is crucial for tumour growth
- (2009) Audrey Ferrand et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Identification and Metastatic Potential of Tumor-Initiating Cells in Malignant Rhabdoid Tumor of the Kidney
- (2009) S. Yanagisawa et al. CLINICAL CANCER RESEARCH
- CD133 and nuclear β-catenin: The marker combination to detect high risk cases of low stage colorectal cancer
- (2009) David Horst et al. EUROPEAN JOURNAL OF CANCER
- Tumour CD133 mRNA expression and clinical outcome in surgically resected colorectal cancer patients
- (2009) R. Artells et al. EUROPEAN JOURNAL OF CANCER
- CD133 is indicative for a resistance phenotype but does not represent a prognostic marker for survival of non-small cell lung cancer patients
- (2009) Alexei V. Salnikov et al. INTERNATIONAL JOURNAL OF CANCER
- Colon cancer stem cells
- (2009) Lucia Ricci-Vitiani et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- The cancer stem cell marker CD133 has high prognostic impact but unknown functional relevance for the metastasis of human colon cancer
- (2009) David Horst et al. JOURNAL OF PATHOLOGY
- Higher percentage of CD133+ cells is associated with poor prognosis in colon carcinoma patients with stage IIIB
- (2009) Chun-Yan Li et al. Journal of Translational Medicine
- Cancer stem cell markers CD133 and CD24 correlate with invasiveness and differentiation in colorectal adenocarcinoma
- (2009) Dongho Choi et al. WORLD JOURNAL OF GASTROENTEROLOGY
- CD133/prominin-1 is a potential therapeutic target for antibody-drug conjugates in hepatocellular and gastric cancers
- (2008) L M Smith et al. BRITISH JOURNAL OF CANCER
- Abnormal DNA Methylation of CD133 in Colorectal and Glioblastoma Tumors
- (2008) J. M. Yi et al. CANCER RESEARCH
- Immunohistochemical detection of CD133 expression in colorectal cancer: A clinicopathological study
- (2008) Motohiro Kojima et al. CANCER SCIENCE
- Promoter hypomethylation regulates CD133 expression in human gliomas
- (2008) Kouichi Tabu et al. CELL RESEARCH
- The Stem Cell Marker CD133 (Prominin-1) Is Expressed in Various Human Glandular Epithelia
- (2008) Jana Karbanová et al. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
- Detection and Characterization of CD133+ Cancer Stem Cells in Human Solid Tumours
- (2008) Virginia Tirino et al. PLoS One
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started